House Medical Technology Caucus To Focus On HCFA At February Meeting
This article was originally published in The Gray Sheet
The first meeting of the House Medical Technology Caucus in the 106th Congress is tentatively scheduled for Feb. 25, according to staffers in the office of Rep. Anna Eshoo (D-Calif.), the co-chair of the group.
You may also be interested in...
Interview: recently appointed CEO Richard Francis will apply his background in big pharma and biotech to building the UK start-up Purespring Therapeutics with a focus on using gene therapy technology to target renal diseases.
Sandoz Canada has become the first manufacturer to launch generic versions of posaconazole and silodosin in Canada. The company launched the generic version of Allergan’s Rapaflo (silodosin) after a Canadian court ruled that Sandoz did not infringe a key formulation patent.
US healthcare insurance provider Health Net failed to respect Amarin’s patent rights in the way it distributed Hikma’s generic version of Vascepa (icosapent ethyl), the originator contends in an expanded induced infringement suit.